SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-133141
Filing Date
2024-05-07
Accepted
2024-05-07 16:20:35
Documents
15
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d825217d8k.htm   iXBRL 8-K 26206
2 EX-99.1 d825217dex991.htm EX-99.1 37056
6 GRAPHIC g825217g0506204907738.jpg GRAPHIC 3904
  Complete submission text file 0001193125-24-133141.txt   205760

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20240507.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20240507_lab.xml EX-101.LAB 19499
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20240507_pre.xml EX-101.PRE 12161
18 EXTRACTED XBRL INSTANCE DOCUMENT d825217d8k_htm.xml XML 3918
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 24922281
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)